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Introduction
The synovial tissue in rheumatoid arthritis (RA) contains
synovial fibroblasts and stromal cells as well as
macrophages. Synovial stromal cells and fibroblasts are
thought to proliferate in situ [1]. On the contrary,
macrophages do not proliferate, but rather differentiate
from monocytes that migrated from the peripheral blood,
and are activated to differentiate in the synovial tissue.
Macrophages in RA synovium secrete many inflammatory
mediators (IL-1, IL-6, IL-8, tumor necrosis factor-a [TNF-a]
and PGE2) and a variety of matrix metalloproteinases, and
are thought to play a central role in the inflammation and
joint destruction characteristic of RA [2]. The number of
macrophages in RA synovium correlates significantly with
clinical symptoms and the degree of joint damage [3].
Understanding the regulation of macrophage accumula-
tion in the RA synovium should therefore provide insight
into the inflammatory nature of rheumatoid synovitis.
Migration of peripheral blood monocytes is likely to be
influenced by chemokines. A number of chemokines,
including IL-8, monocyte chemotactic protein-1 (MCP-1),
macrophage inflammatory protein-1a (MIP-1a), MIP-1b,
epithelial-derived neutrophil attractant 78, and regulated
upon activation, normal T cell expressed and secreted
(RANTES), are known to be found in RA synovial fluid
[4–8]. A number of specific chemokine receptors includ-
ing CCR1, CCR2, CCR5, CCR8, and CXCR4 are also
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known to be expressed by peripheral blood monocytes
[9,10]. Despite this information, the specific chemokine–
chemokine receptor interactions involved in the recruit-
ment of monocytes into the rheumatoid synovium have not
been fully delineated.
To address this issue, we examined chemokine receptor
expression by peripheral blood monocytes, and also ana-
lyzed the capacity of supernatants from RA synovial
stromal cells to induce monocyte migration. The data indi-
cate that MCP-1 secreted by synovial stromal cells plays a
major role in attracting monocytes to the synovium, and
that IL-8 may also contribute.
Materials and methods
Antibodies and reagents
Biotinylated mouse anti-human CCR1 monoclonal anti-
body (mAb), mouse anti-human CCR2 mAb conjugated
with phycoerythrin (PE), mouse anti-human CCR6 mAb
conjugated with PE, mouse anti-human CXCR1 mAb con-
jugated with PE, mouse anti-human CXCR2 mAb conju-
gated with PE, mouse anti-human CXCR5 mAb
conjugated with PE, mouse anti-human CCR3 mAb conju-
gated with FITC, mouse anti-human MCP-1 mAb
(24822.111), mouse anti-human IL-8 mAb (6217.111),
mouse anti-human IP-10 mAb (33036.211), mouse anti-
human CCR5 mAb (45531.111), and biotinylated goat
IgG anti-human IP-10 were purchased from R&D Systems
Inc (Miami, FL). Mouse anti-human CCR5 mAb conju-
gated with FITC and mouse anti-human CXCR4 mAb con-
jugated with PE were purchased from Pharmingen (San
Diego, CA). Mouse anti-human CD14 mAb conjugated
with FITC or PE, and Streptavidin conjugated with PE
were obtained from Sigma (St Louis, MO). Mouse IgG1
mAb was prepared from hybridoma cell lines purchased
from ATCC (Rockville, MD). Mouse IgG2A conjugated
with PE (Pharmingen), mouse IgG2B conjugated with PE
(R&D Systems), and mouse IgG1 conjugated with FITC
(Becton Dickinson, San Jose, CA) were used for negative
controls for flow cytometry.
Recombinant human TNF-a, RANTES, interferon-gamma
inducible protein 10 (IP-10), and stromal cell derived
factor-1a were purchased from R&D Systems. Trizol
reagent, deoxyribonuclease I, and SuperScript II reverse
transcriptase were purchased from Gibco BRL (Rockville,
MD). Taq polymerase was purchased from Promega
(Madison, WI), and Oligo dT and ficoll/isopaque were pur-
chased from Pharmacia (Piscataway, NJ). DMEM with
high-glucose, RPMI-1640, and FBS were purchased from
Gibco BRL.
Enzyme-linked immunosorbent assays (ELISAs) for
MCP-1, IL-8, MIP-1b, and RANTES were purchased from
R&D Systems, and transwell membranes (5mm pore size
in 24 wells) were purchased from Costar (Cambridge,
MA). The TMB microwell peroxidase substrate system was
purchased from KPL (Gaithersburg, MD).
Stromal cell lines and fibroblast lines
One RA stromal cell line (SCL) was established from syn-
ovium as previously described [11]. In brief, synovial tissue
of a patient with RA who met American College of
Rheumatology criteria [12] was obtained following
informed consent, and dissociated with collagenase and
trypsin. Dissociated cells were cultured in DMEM supple-
mented with 10% FBS and 10% conditioned medium,
which was prepared by incubation of peripheral blood
mononuclear cells from 10 healthy donors in RPMI-1640
medium with 10% FBS for 48h. The cultures were then
maintained for more than 2 months, and the SCLs were
cloned by limiting dilution. Clones were thereafter main-
tained and replenished with fresh DMEM medium with 10
or 20% FBS every 3–4 days. One clone (Sy77) was used
in the present experiments. RA tissues from two other
patients were also dissociated with collagenase and
trypsin. Dissociated cells were cultured in DMEM supple-
mented with 10% FBS and 10% conditioned medium and
used as RA SCLs (RA6/1 and RA8/3) after 4–10 pas-
sages. An SCL was also established from osteoarthritis
synovium (OA5/26) using the same procedure. A skin
fibroblast line (FBHG) was also established from a healthy
human skin sample.
SCL and fibroblast culture
RA SCL, osteoarthritis (OA) SCL, and skin fibroblasts
( 1×1 0 5) were seeded in six-well culture plates (Costar)
with DMEM containing 10% FBS, 200U/ml penicillin G,
10mg/ml gentamicin and 0.3mg/ml L-glutamine, and cul-
tured for 3 days. After culturing, the cells were washed
once and the medium was changed to DMEM containing
5% FBS, 200U/ml penicillin G, 10mg/ml gentamicin, and
0.3mg/ml L-glutamine with or without 2ng/ml TNF-a. To
assess chemokine mRNA expression, cell lines were har-
vested after 4h of culture, then suspended in Trizol and
stored at –80°C. Supernatants were collected after 24h
and stored at –80°C until use for migration assay and
quantification of chemokines.
Preparation of mononuclear cells
Peripheral blood mononuclear cells (PBMC) were isolated
from heparinized blood of healthy adult volunteers by
density sedimentation using ficoll/isopaque. PBMC were
cultured with sheep red blood cells (SRBC) treated for
70 min at 4°C, and rosette negative cells were collected
by ficoll/isopaque sedimentation.
Chemokine receptor expression by monocytes
Chemokine receptor expression by monocytes was
assessed by dual immunofluorescence flow cytometry fol-
lowing staining with anti-CD14 mAb and anti-chemokine
receptor mAbs (FACScan; Becton Dickinson). For stain-Arthritis Research    Vol 3 No 2 Hayashida et al
ing chemokine receptors, 10ml of each mAb was used for
1×10 5 cells suspended in 100ml staining buffer (PBS +
2% FBS) in accordance with the manufacturer’s instruc-
tions.
Migration assay
Cell migration was assessed in 24-well chemotaxis cham-
bers fitted with 5.0mm transwell membranes. Super-
natants (550ml) of cell lines cultured in various conditions
were added to the lower wells, and 5×105 SRBC rosette
negative PBMC in 100ml DMEM containing 5% FBS were
added to the upper wells. In blocking experiments, the
supernatants were cultured with blocking mAbs specific
for chemokines overnight at 4°C before assay. SRBC
rosette negative PBMC were incubated with blocking
mAb to chemokine receptors for 1h at 4°C before assay
in some experiments. The transwell membranes were
removed after 90 min of incubation at 37°C, and migrated
cells in the lower chamber were harvested by pipetting.
The cells were stained with anti-CD14 mAb conjugated
with FITC, and they were suspended in 110ml PBS con-
taining 3% FBS. All of the cells were analyzed by flow
cytometry and CD14+ cells were counted.
RNA isolation and reverse transcriptase-polymerase
chain reaction
RNA was extracted from SCLs and fibroblasts using Trizol
reagent in accordance with the manufacturer’s instructions.
Two micrograms of the extracted RNA was treated with
2U DNase I to eliminate DNA, and reverse transcribed with
200 U SuperScript II reverse transcriptase at 42°C for
70 min using oligo dT primers in accordance with the man-
ufacturer’s instructions. Polymerase chain reaction (PCR)
was carried out with Taq polymerase using 0.1–0.3ml
cDNA (1.5mM MgCl2). Denaturation and extension condi-
tions were 94°C for 1 min and 72°C for 1 min, respectively.
The annealing period was 1 min for each PCR, and the
temperature was 62°C for RANTES and 56°C for the other
chemokines and b-actin. PCR products were resolved by
electrophoresis on 1.5% agarose gels and identified with
ethidium bromide staining. Firstly, b-actin expression was
examined using 26–30 cycles of reverse transcriptase-
PCR (RT-PCR) to amplify 0.1, 0.2, and 0.3ml cDNA to
adjust the amount of cDNA of each sample precisely. After
resolving the PCR products on agarose gels and identify-
ing the relevant bands with ethidium bromide, the optimal
amounts of cDNA for analysis were then determined.
Chemokine expression in this amount of cDNA was exam-
ined using 30, 32, 35, 38, and 40 cycles of PCR amplifica-
tion, and the results in the linear part of the amplification
curve are reported in the figures.
PCR primers
The primer pair for b-actin was GTC CTC TCC CAA GTC
CAC ACA (forward) and CTG GTC TCA AGT CAG TGT
ACA GGT AA (reverse), that of IL-8 was CTG CGC CAA
CAC AGA AAT TA (forward) and ATT GCA TCT GGC
AAC CCT AC (reverse), that of MCP-1 was GCC TCC
AGC ATG AAA GTC TC (forward) and TAA AAC AGG
GTG TCT GGG GA (reverse), that of IP-10 was CCA CGT
GTT GAG ATC ATT GC (forward) and TGG AAG ATG
GGA AAG GTG AG (reverse), that of RANTES was CGC
TGT CAT CCT CAT TGC TA (forward) and GCT GTC
TCG AAC TCC TGA CC (reverse), that of MIP-1a was
TGC AAC CAG TTC TCT GCA TC (forward) and ACA
GGG GAA CTC TCA GAG CA (reverse), and that of
MIP-1b was CTG GGT CCA GGA GTA CGT GT (forward)
and ACA GTG GAC CAT CCC CAT AG (reverse).
ELISA
Concentrations of chemokines were measured by sand-
wich ELISA according to the manufacturer’s instructions
(R&D Systems).
Statistical analysis
The Student paired t test was used to compare the effect
of CD14 cell migration, and the blocking effect of mAbs.
The Student t test was used to evaluate chemokine pro-
duction by SCLs and the fibroblast line.
Results
Chemokine receptor expression by peripheral blood
monocytes
Chemokine receptor expression by CD14+ monocytes was
examined using flow cytometry. Representative examples
(Fig. 1) and a summary of staining results (Table 1) are pre-
sented. CXCR3 and CXCR4 were expressed by a high fre-
quency of monocytes in all healthy donors. More than
one-half of monocytes expressed CCR2, CCR5, CXCR1,
and CXCR2 in seven of nine cases, although a minimal
number of monocytes from two donors expressed these
receptors. Expression of CCR6 and CXCR5 by monocytes
was minimal in all subjects. CCR1 was expressed by few
monocytes in three donors, whereas 20–40% of mono-
cytes of the other donors expressed CCR1. These results
suggest that CCR1, CCR2, CCR5, and CXCR1, CXCR2,
CXCR3, and CXCR4 are candidates to be involved in
chemokine-mediated trafficking of monocytes.
Supernatants of cell lines attract monocytes
To examine whether SCLs derived from RA synovium can
attract monocytes efficiently, migration of monocytes in
response to culture supernatants of RA and OA SCLs and
fibroblasts was examined (Fig. 2). Supernatants of all cell
lines attracted significantly more monocytes than medium
alone (P<0.01). Those supernatants from RA SCLs
induced the migration of significantly more monocytes
than the supernatants of the OA SCL and skin fibroblasts.
Chemokine mRNA production by cell lines
Production of proinflammatory chemokine mRNA by the
various cell lines was assessed using RT-PCR (Fig. 3). RASCLs expressed a number of proinflammatory chemokine
mRNAs, including MCP-1, IL-8, MIP-1a, MIP-1b,
RANTES, and IP-10. OA SCL also expressed these same
chemokine mRNAs with the exception of MIP-1b. The
fibroblast line expressed mRNAs for IL-8, MCP-1, and
IP-10, but not RANTES, MIP-1a, and MIP-1b.
Chemokine production by cell lines
Chemokines secreted into the culture supernatants of cell
lines were measured by ELISA (Fig. 4). Production of
MCP-1 and IL-8 by RA SCLs was greater than that by OA
SCL and the fibroblast line. The cell lines produced low
levels of RANTES, whereas IP-10 and MIP1-b were not
detected (data not shown).
MCP-1 and IL-8 play a role in migration of monocytes
Blocking experiments were carried out using mAbs to
determine the chemokines that contribute to monocyte
migration induced by RA SCLs (Fig. 5). Anti-MCP-1 and
anti-IL-8 mAbs decreased monocyte migration signifi-
cantly, with the effect of anti-MCP-1 being consistently
greater than that of anti-IL-8. Anti-CCR5 blocking mAb did
not effect monocyte migration. The anti-CCR5 mAb did
have blocking activity, however, since migration of T cells
induced by RANTES (500ng/ml) was blocked by 95%
(data not shown).
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Figure 1
Chemokine receptor expression by peripheral blood monocytes.
Peripheral blood SRBC rosette negative cells (1 × 105) were stained
with anti-CD14 mAb and various chemokine receptor mAbs, and were
analyzed by flow cytometry. CD14+ cells were gated, and chemokine
receptor expression by the CD14+ monocytes is shown (solid line).
Dotted lines show staining by isotype-matched control mAb.
Percentage of positive cells is also shown in the histograms. Staining
was from one of nine experiments. FL-1 height, FITC fluorescence; 
FL-2 height, PE fluorescence.
Figure 2
Monocyte migration induced by supernatants of various cell lines. An
assay of monocyte migration was performed using supernatants of
various cells. Each cell line (1 × 105/well) was cultured in six-well
culture plates with 2 ml DMEM supplemented with 5% FBS.
Supernatants were collected after 24 h of incubation, and were used
for assay. Migrated cells were stained with anti-CD14 mAb, then the
number of migrated CD14+ cells was assessed by flow cytometry.
RA6/1, RA8/3, and Sy77 are RA SCLs, OA5/26 is a SCL from OA,
and FBHG is a skin fibroblast line. The mean and SEM were calculated
with data from 11 independent experiments. Statistical analysis was
performed with the paired Student t test. * P < 0.05 and ** P < 0.01.Stimulation with TNF-a a induces RA SCL to produce
more chemokines and attract more monocytes
RA SCLs were stimulated with TNF-a, and chemokine
production and the capacity of supernatants to influence
monocyte migration were examined to assess the influ-
ence of inflammatory cytokines on chemokine production
and monocyte trafficking. Supernatants from RA SCLs
stimulated with 2ng/ml TNF-a produced more MCP-1,
IL-8, RANTES and IP-10 (Fig. 6), and attracted more
monocytes (Fig. 7) than those that were unstimulated.
MCP-1 and IL-8 play major roles in monocyte migration
by RA SCLs after TNF-a a stimulation
Anti-MCP-1 mAb and anti-IL-8 mAb significantly inhibited
monocyte migration by supernatants of RA SCLs stimu-
lated with TNF-a. Anti-IP-10 mAb and anti-CCR5 mAb did
not inhibit monocyte migration significantly (Fig. 8).
Discussion
The results of this study indicate that supernatants of SCL
derived from RA synovial tissue can attract more mono-
cytes from peripheral blood than OA SCL and skin fibro-
blasts. MCP-1 and, to a lesser degree, IL-8 played the
major roles in SCL-induced trafficking of monocytes. These
results begin to provide an explanation for the extensive
accumulation of myeloid cells in rheumatoid synovium.
Importantly, RA SCL induced more monocyte migration
after stimulation with TNF-a, one of the major inflammatory
cytokines produced in the rheumatoid synovium.
Peripheral blood monocytes express many chemokine
receptors [9,10], including CCR1, CCR2, CCR5, CCR8,
and CXCR4. The current analysis indicates that, along
with these receptors, CXCR1, CXCR2, and CXCR3 are
also expressed by monocytes. CCR1, CCR2, CCR5,
CXCR1, CXCR2, CXCR3, and CXCR4 notably appear to
be expressed by monocytes obtained from most donors.
Ligands of these chemokine receptors are candidates to
be involved in monocyte trafficking. These ligands would
include RANTES, MIP-1a and MCP-3 (CCR1), MCP-1,
MCP-2, MCP-3, MCP-4, MCP-5 (CCR2), RANTES,
MIP-1a, and MIP-1b (CCR5), IL-8 and CGP-2 (CXCR1),
IL-8, GROa, and epithelial-derived neutrophil attractant 78
(CXCR2), IP-10 and MIG (CXCR3), and stromal cell
derived factor-1 (CXCR4) [13]. Migration assays using
supernatants of RA SCLs were employed to determine
which of these chemokine and receptor interactions might
be involved in monocyte migration in the RA synovium.
Stromal cells are one of the important cell populations in
RA synovium. SCL can produce many cytokines, chemo-
kines, and can promote viability and functional activation
of T cells and B cells [14–16]. The current findings also
Arthritis Research    Vol 3 No 2 Hayashida et al
Table 1
Chemokine receptor expression by CD14+ monocytes
Positive expression
CCR1 CCR2 CCR5 CCR6 CXCR1 CXCR2 CXCR3 CXCR4 CXCR5
Mean (%) 26.8 51.1 41.6 9.5 58.2 51.3 73.6 68.2 2.8
Range 3–43 12–81 0.8–76 5–14 7–79 2–81 51–88 34–88 2–4
Sheep red blood cell rosette negative cells from nine healthy donors were stained with anti-CD14 monoclonal antibody and anti-chemokine
receptor monoclonal antibodies, and were analyzed by flow cytometry. CD14-positive cells were gated, and chemokine receptor expression by
CD14+ cells was analyzed. The mean percent and range of positive cells are shown.
Figure 3
Chemokine mRNA expression by various cell lines. Chemokine mRNA
expression was examined with RT-PCR. PCR products were separated
in 1.5% agarose gels and analyzed after ethidium bromide staining.
Each PCR was performed using 0.1 ml cDNA sample and the number
of PCR cycles indicated. RA6/1, RA8/3, and Sy77 are RA SCLs,
OA5/26 is a SCL from OA, and FBHG is a skin fibroblast line.indicate that supernatants of RA SCLs attract more mono-
cytes than the supernatants of OA SCL and skin fibrob-
lasts. This result suggests that the supernatants from
RA SCLs may contain more chemokines than or different
chemokines to those of OA SCL or fibroblast lines and,
therefore, are able to attract additional monocytes. This is
likely to contribute to the more marked accumulation of
monocytes in RA compared with OA synovium.
An analysis of chemokines produced by RA SCL indicated
that these cells expressed MCP-1 and IL-8 mRNAs, and
also secreted MCP-1 and IL-8. It is noteworthy that there
were some discrepancies between mRNA expression and
protein production. From the mRNA expression, we
expected RA SCLs to produce reasonable amounts of
IP-10, RANTES, MIP-1a, and MIP-1b. RA SCLs, however,
secreted only small amounts of RANTES, and IP-10 and
MIP-1b secretion was not detected. According to previous
reports, mRNAs of MCP-1, IL-8, and RANTES were found
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Figure 4
Chemokine production by various cell lines. Production of MCP-1, IL-8,
RANTES, IP-10, and MIP-1b was measured by ELISA. Various cell
lines (1 × 105/ml) were cultured for 24 h with 2 ml DMEM containing
5% FBS, and supernatants were collected. The contents of (A) MCP-
1, (B) IL-8, and (C) RANTES are shown; MIP-1b and IP-10 were not
detected (less than 10 pg/ml). RA6/1, RA8/3, and Sy77 are RA SCLs,
OA5/26 is a SCL from OA, and FBHG is a skin fibroblast line. The
mean and SEM were calculated from triplicates of one representative
experiment out of three with similar results. Statistical analysis was
performed with the Student t test. * P < 0.05 and ** P < 0.01.
Figure 5
Blocking of monocyte migration induced by RA SCL supernatants with
blocking anti-chemokine or chemokine receptor mAbs. Monocyte
migration induced by supernatants of RA SCLs (RA6/1 and RA8/3)
was assessed using mAbs, which can neutralize specific chemokines
or chemokine receptors. Concentrations of mAbs were 10 mg/ml for
MCP-1, IL-8, and IP-10, and 50 mg for anti-CCR5 mAb with 5 × 105
SRBC rosette negative cells. Migrating cells were stained with anti-
CD-14 mAb, and migrating CD14+ cells were counted by flow
cytometry. The mean and SEM were calculated from the results of nine
independent experiments. The paired Student t test was used to
assess statistical differences versus the result with control mAb.in RA SCL or fibroblasts, but only MCP-1 was reported to
be secreted by RA SCL or fibroblasts without cytokine
stimulation [4,5,17,18]. The current study indicates a
wider profile of chemokine expression and secretion by
RA SCL, and also a greater production of IL-8 and MCP-1
by RA SCL compared with OA SCL, implying a greater
proinflammatory potential.
Experiments with blocking mAbs were carried out to
examine the chemokines in the supernatants of SCL that
accounted for monocyte migration. The data were consis-
tent with the conclusion that MCP-1 and, to a lesser
extent, IL-8 accounted for the capacity of RA SCL super-
natants to stimulate monocyte migration. Whether addi-
tional cytokines produced by RA SCL also contributed to
monocyte migration is currently not known, but the combi-
nation of the chemokine data and the mAb blocking
results suggests that MCP-1 and IL-8 play a dominant role
in monocyte migration measured by SCL.
TNF-a is one of the major cytokines produced in inflamma-
tory sites such as RA synovium, and it is thought to play a
central proinflammatory role [2]. We examined the influ-
ence of TNF-a on monocyte migration induced by
RA SCL. RA SCLs stimulated by TNF-a secreted more
MCP-1, IL-8, and RANTES than those that were unstimu-
lated, and began to produce IP-10. Moreover, super-
natants of TNF-a-stimulated RA SCLs attracted more
monocytes in migration assay. MCP-1 and IL-8 played the
main roles in monocyte migration induced by TNF-a-stimu-
lated RA-SCL, as documented by blocking experiments.
It has recently been reported that T cells expressing CCR5
gather at inflammatory sites such as RA or multiple sclero-
sis, and that interactions between CCR5 and its ligands
(RANTES, MIP-1a, MIP-1b) are thought to be important in
the accumulation of inflammatory cells at these sites
[19–21]. CCR5 expressed by monocytes, however, was
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Figure 6
Chemokine production by RA SCL stimulated with TNF-a. Production
of MCP-1, IL-8, RANTES, IP-10, and MIP-1b was measured by ELISA.
Various cell lines (1 × 105/ml) were cultured for 24 h in 2 ml DMEM
containing 5% FBS with or without 2 ng/ml TNF-a, and supernatants
were collected. The content of (A) MCP-1, (B) IL-8, (C) RANTES and
(D) IP-10 are shown; MIP-1b was not detected (less than 10 pg/ml).
RA6/1, RA8/3, and Sy77 are RA SCLs. The mean and SEM were
calculated from triplicates of one representative experiment out of
three with similar results. Statistical analysis was performed with the
Student t test. * P < 0.05 and ** P < 0.01.
Figure 7
Monocyte migration induced by supernatants of RA SCLs stimulated
with TNF-a. Assay of monocyte migration was performed using
supernatants of RA SCLs stimulated with TNF-a. Each RA SCL
( 1×1 0 5/well) was cultured in six-well culture plates with 2 ml DMEM
supplemented with 5% FBS with or without 2 ng/ml TNF-a.
Supernatants were collected after 24 h of incubation, and were used
for assay. Migrated cells were stained with anti-CD14 mAb, then the
number of migrated CD14+ cells was assessed by flow cytometry.
RA6/1, RA8/3, and Sy77 are RA SCLs. The mean and SEM were
calculated from three independent experiments. Statistical analysis was
performed with the paired Student t test. * P < 0.05 and ** P < 0.01.not apparently active in transmitting transmigratory signals.
RANTES is also the ligand of CCR1, but the major recep-
tor for RANTES is thought to be CCR5. In this regard,
expression of CCR1 by monocytes was lower than that of
CCR5. Moreover, antibody to MCP-1 and IL-8 blocked
75% and 20% of migration of monocytes, respectively.
According to this information, RANTES is unlikely to play a
major role in monocyte migration by RA SCL supernatants.
MCP-1 has been shown to play an important role in the
development of arthritis in MRL-lpr mice [22], whereas the
migration of monocytes into inflammatory sites was
reduced in the CCR2-deficient mouse [23]. These results
are consistent with the current findings, demonstrating the
important role of MCP-1 in monocyte migration. Blocking
the effect of RANTES has, however, also been shown to
be effective in ameliorating collagen-induced arthritis in
DAB/1 mice and adjuvant-induced arthritis in rats [24,25].
RANTES might, therefore, play a different role in the initia-
tion of inflammatory arthritis in experimental animals com-
pared with propagating chronic inflammation in RA.
The overlapping roles of MCP-1 and IL-8 in the migration
of inflammatory cells have recently been highlighted in
studies of neutrophil trafficking. It was reported that
MCP-1 plays a role in neutrophil trafficking in inflamma-
tion, although neutrophil trafficking was previously
believed to be regulated only by IL-8, and not by MCP-1
[26]. These previous results, together with the current
data, indicate that both MCP-1 and IL-8 play major roles in
regulating the trafficking of myeloid cells into inflammatory
sites.
The role of specific chemokines in arthritis is still contro-
versial, and further investigation is necessary to delineate
to specific roles of these effector molecules. Moreover,
the role of tissue cells in regulating the migration of inflam-
matory cells into the synovium is also not fully established.
The current data, however, strongly imply that monocyte
accumulation in rheumatoid synovium is regulated by SCL
via production of the chemokines MCP-1 and IL-8.
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stimulated with TNF-a. Monocyte migration induced by supernatants of
RA SCLs (RA6/1 and RA8/3) stimulated with 2ng/ml TNF-a was
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